The first government of the United Arab Emirates has approved the Chinese coronavirus vaccination

The need to clarify the safety and efficacy of Chinese vaccines became more urgent after Sinopharm found out that it had vaccinated roughly one million people before clinical trials were completed. The campaign has alarmed overseas scientists who say it exposes people to unreasonable risks.

Chinese officials have repeatedly assured the public that the country’s coronavirus vaccines are safe, yet provide little detail. Last month, Liu Jingzhen, a Sinopharm said none of the people receiving the company’s vaccine experienced any side effects. He said “only a few had mild symptoms”.

In October, senior health official Zheng Zhongwei said the government had set up a “follow-up program” to track vaccinated people, although no details were provided.

Beijing-based Sinovac Biotech, a manufacturer of vaccines, has already begun exporting its vaccines to countries such as Indonesia and Brazil. Sinopharm, which has another vaccine in its late-stage tests, said it is preparing to deliver 500 million doses worldwide, the state newspaper Science and Technology Daily writes.

It is unclear whether the Emirates will start using the Chinese vaccine – which is provided by Sinopharm developed by the Beijing Institute of Biological Products – for mass vaccinations. As early as September, the government approved the vaccine for emergency use for those working on the front at risk of Covid-19 infection.

In some other countries where Sinopharm is conducting experiments, Chinese vaccines are being counted to protect their populations. Morocco says it is preparing to vaccinate 80 percent of adults, initially relying on Sinopharm vaccination, although Moroccan news site Médias24 says China would wait for the vaccine to be approved.

Chinese vaccines are also attractive to developing countries because they are easier to distribute. According to Sinopharm, your vaccines should only be refrigerated at 2 to 8 degrees Celsius (or 35 to 46 degrees Fahrenheit) and may remain stable for up to three years. In contrast, vaccinations from Pfizer and Moderna, which are made with genetic material that disintegrates when thawed, require industrial freezers, making transportation and storage more difficult.